The series C for Utah-founded drug discovery platform creator Recursion included capital from University of Minnesota and Texas Tech University System.

Naspers is in talks to lead the $500m round, which is also expected to feature NeoPlux and will reportedly value the food delivery platform at $4bn.

Cancer treatment company Biontech raised $325m round backed by Fidelity. The company forms part of the hopeful oncology and cancer treatment subsector of life sciences which has seen much growth and in corporate backing in recent years.

Corning, Cornes and Volvo have invested in Luminar, which has emerged with more than $250m in funding, including a $100m round closed recently.

Signavio has raised $177m in equity financing from Deutsche Telekom Capital Partners and Apax Digital to further develop its business process management software.

Creditas has received $231m in series D funding from investors including SoftBank through its Latin America Fund and Vision Fund, and Santander.

Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.

Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.

Tencent and Naspers-backed education platform Byju’s is targeting an expansion into the US, the UK, Australia and New Zealand following the $150m funding round.

Third Rock contributed to a $100m series C round for UIC's cancer drug developer Revolution that brought its total to $226m.